Assay Framework


Identity. Specification. Release Control.

At HOLOGRAMโ„ข, quality is determined by documented specification compliance โ€” not marketing language.

Each production lot undergoes a structured quality verification process prior to release. Our Assay Framework is designed to confirm identity, specification alignment, contaminant screening, regulatory evaluation, and traceability in accordance with Good Manufacturing Practice (GMP) requirements for dietary supplements.


Lot-Based Quality Verification

Every finished lot of HOLOGRAMโ„ข is evaluated against predefined, documented product specifications established prior to production. Quality review includes analytical testing, manufacturing record review, and documented release authorization.


1. Identity Verification

Purpose: To confirm the material corresponds to the intended peptide fraction profile and finished formulation.

May include:

โ€ข Raw material identity confirmation

โ€ข Finished product verification against documented specifications

โ€ข Analytical techniques appropriate to peptide-containing materials (e.g., chromatographic or spectrometric methods where applicable)

Identity testing supports assurance that the finished product matches the intended formulation.


2. Dosage Assurance & Controlled Overage

HOLOGRAMโ„ข is formulated with a controlled manufacturing overage of up to 5%, where applicable.

This controlled buffer is applied within strict internal tolerances to help:

โ€ข Maintain labeled quantities throughout the productโ€™s intended shelf life

โ€ข Account for normal analytical variability

โ€ข Support consistency from production through distribution

โ€ข Reduce the likelihood of falling below declared specifications

The purpose of this overage is not to exceed label claims, but to help support alignment with declared specifications under normal storage conditions.

Each lot is evaluated against predefined specifications prior to release.


3. Specification & Label Alignment

Purpose: To verify manufacturing consistency and alignment with declared product specifications.

May include:

โ€ข Capsule fill weight verification

โ€ข Net weight confirmation

โ€ข Batch production record review

โ€ข Label reconciliation checks

โ€ข Finished goods inspection

This process supports consistency between manufacturing documentation and labeled presentation.


4. Heavy Metal Screening & Proposition 65 Evaluation

Purpose: To screen for elemental contaminants and evaluate exposure levels against applicable regulatory reference limits.

Testing panels may include:

โ€ข Lead (Pb)

โ€ข Arsenic (As)

โ€ข Cadmium (Cd)

โ€ข Mercury (Hg)

Where applicable, testing may utilize ICP-MS or equivalent validated methodologies.

Finished product exposure levels are evaluated against relevant dietary supplement safety reference limits and California Proposition 65 safe harbor exposure limits for listed heavy metals, where applicable.


5. Microbiological Quality Screening

Purpose: To assess microbial quality consistent with supplement safety standards.

Testing may include:

โ€ข Total aerobic microbial count

โ€ข Yeast and mold

โ€ข Screening for specified pathogens (e.g., Salmonella spp., Escherichia coli) where appropriate

Finished product is released only if microbial parameters meet established specifications.


6. Allergen & Cross-Contamination Controls

Purpose: To reduce risk of unintended allergen exposure.

Manufacturing controls may include:

โ€ข Supplier documentation review

โ€ข Allergen risk assessment

โ€ข Segregated handling protocols where required

โ€ข Controlled production environments


7. Stability & Handling Controls

Purpose: To support product integrity throughout storage and distribution.

Includes:

โ€ข Controlled environmental storage

โ€ข Packaging integrity verification

โ€ข Lot traceability systems

โ€ข Documented release authorization procedures


Third-Party Laboratory Verification

Where third-party testing is performed, qualified independent laboratories are selected based on analytical capability and methodological fit. Testing panels may vary depending on ingredient class, risk assessment, and regulatory requirements.


Lot Traceability

Each bottle of HOLOGRAMโ„ข carries a lot code.

This code links to:

โ€ข Production date

โ€ข Batch documentation

โ€ข Quality review records

โ€ข Applicable analytical reports

Traceability supports internal quality assurance and regulatory compliance.


Release Criteria

A production lot is released only after:

โœ“ Identity parameters meet established specifications

โœ“ Contaminant screening falls within defined limits

โœ“ Microbial parameters meet established standards

โœ“ Manufacturing documentation is reviewed and approved

โœ“ Packaging and labeling checks are complete

Any lot that does not meet established specifications is subject to documented hold procedures and is not released for distribution unless resolved in accordance with quality control protocols.


Quality Position Statement

HOLOGRAMโ„ข is manufactured in accordance with Good Manufacturing Practice (GMP) requirements for dietary supplements in an FDA-registered facility.

Finished product exposure levels are evaluated against applicable safety reference limits, including California Proposition 65 safe harbor exposure limits where relevant.

We rely on documented specification compliance and controlled release procedures to support consistency and transparency.


These statements describe quality control procedures and manufacturing standards.